Cost-effectiveness analysis of capecitabine plus bevacizumab versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer from Chinese societal perspective

作者：Pei Zhang, F. Wen, Jing Zhou, JT Huang, Kunlu Zhou, Qiuji Wu, Xin Wang, Menghan Zhang, Wei‐Ting Liao, Qiu Li · 发表于：Clinical & Translational Oncology · 年份：2019 · DOI：10.1007/s12094-019-02114-x · 被引用次数：14 · 研究领域：Colorectal Cancer Treatments and Studies、Economic and Financial Impacts of Cancer、Cancer Treatment and Pharmacology